Industry News
Pharmaceutical Industry News
The Wonder Drug That’s Plaguing Sports
Ostarine held the promise of profound medical treatments. Something unexpected happened on the way to F.D.A. approval.
Sanofi, Novo Nordisk, UCB and…
Sanofi, Novo Nordisk, UCB and others received positive opinions from Europe's Committee for Medicinal Products for Human Use, while Amgen's approved Tavneos is up for a re-review due to data integrity concerns.
For the last several quarters,…
For the last several quarters, declining sales of Regeneron's eye disease treatment Eylea have exceeded increasing sales of the drug's new version, Eylea HD, leading to a steady decline in overall U.S. sales for the
Quince Therapeutics’ novel…
Quince Therapeutics’ novel method of delivering steroids in a patient’s own red blood cells turned out to be a bust in ataxia-telangiectasia, a rare inherited disorder, with the company now planning to “preserve cash and
On Friday, Eli Lilly unveiled…
On Friday, Eli Lilly unveiled designs on a new, $3.5 billion manufacturing facility in Pennsylvania’s Lehigh Valley, rounding out the quartet of plants it promised during its “Lilly in America” investment announcement last year.
Some officials in the Trump…
Some officials in the Trump administration are at odds with others who are helping shape vaccine policy over whether to remove COVID vaccines from the U.S. market, according to a report from Axios.
The German CDMO devoted 480…
The German CDMO devoted 480 million euros ($574.3 million) to the first construction phase for a new plant in Saarlouis, Germany, which is expected to be operational by 2031.
This week on “The Top Line,” we…
This week on "The Top Line," we explore biopharma's rebound, dealmaking momentum and what's cutting through the noise in 2026.
AstraZeneca made a big commitment…
AstraZeneca made a big commitment to China as CEO Pascal Soriot joined British Prime Minister Keir Starmer on a trip to the country. Boehringer Ingelheim secured a preclinical inflammatory bowel disease bispecific from Simcere. Daiichi
On Wednesday, the U.S. Chamber of…
On Wednesday, the U.S. Chamber of Commerce filed an amicus brief calling on the Supreme Court to review a lower court decision that previously rejected Novo Nordisk's challenge of drug pricing provisions in the Inflation
The minute-long ad, which debuted…
The minute-long ad, which debuted online Thursday ahead of its broadcast premiere during the Feb. 8 game, starts with a stark claim: “Rich people live longer,” said by the ad’s narrator, the rapper and actor
A few months after sending an…
A few months after sending an untitled letter to ARS Pharmaceuticals, taking issue with certain aspects of a TV commercial about its epinephrine nasal spray, the FDA is reiterating its concerns about Neffy’s advertising language.
The gap between Vyvanse generic…
The gap between Vyvanse generic sales declines and growth from new products is narrowing, the Japanese company said on its third-quarter 2025 earnings call, which detailed financial performance from the nine months ending on Dec.
Amid mounting concerns about the…
Amid mounting concerns about the state of vaccine policy in the United States, Sanofi is keeping a cool head while acknowledging that sales of its immunizations are slated to dip slightly this year. The comments
Roche is looking to a busy 2026…
Roche is looking to a busy 2026 after 10 new molecules entered late-stage testing last year and as a potential launch of closely watched breast cancer candidate giredestrant draws near. But behind another strong earnings
Bayer has unveiled the next play…
Bayer has unveiled the next play in its Nubeqa marketing strategy, tapping NFL quarterback-turned-CBS commentator Tony Romo for a campaign in support of its fast-growing prostate cancer drug.
Combining two eye drops that have…
Combining two eye drops that have been on the market for at least 30 years each has earned Tenpoint Therapeutics an FDA approval for Yuvezzi, a treatment for presbyopia, a common, age-related condition that makes
A year after debuting its first…
A year after debuting its first Super Bowl ad, Novartis is returning to advertising’s biggest stage on another awareness-raising mission, this time focusing on boosting prostate cancer screening.
Consumer advocacy organization…
Consumer advocacy organization Public Citizen has filed a Freedom of Information Act lawsuit against the Department of Health and Human Services and the Department of Commerce for failing to provide documents related to President Donald Trump’s
The pediatric medical group…
The pediatric medical group recommends children be vaccinated against 18 diseases, as opposed to the federal government's recent reduction to 11.